Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Chevron
CVX
$388B
| $173M | 0.19% |
+1,378,984
| New | +$164M |
|
|
MBT
102
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $172M | 0.19% |
16,858,600
+2,674,500
| +19% | +$27.6M |
|
103
Telus
TU
$16B
| $169M | 0.19% |
8,950,200
+1,079,800
| +14% | +$20M |
|
104
Jazz Pharmaceuticals
JAZZ
$15.9B
| $168M | 0.18% |
1,244,800
+28,700
| +2% | +$3.98M |
|
105
Molina Healthcare
MOH
$10.3B
| $165M | 0.18% |
2,156,150
+751,800
| +54% | +$54.3M |
|
106
IAMGOLD
IAG
$8.47B
| $162M | 0.18% |
27,774,896
+3,382,000
| +14% | +$19.3M |
|
107
Live Nation Entertainment
LYV
$41.2B
| $160M | 0.18% |
3,767,366
+758,666
| +25% | +$33M |
|
108
Booking.com
BKNG
$138B
| $160M | 0.18% |
+2,299,975
| New | +$167M |
|
109
Intel
INTC
$466B
| $159M | 0.18% |
3,441,594
+3,338,000
| +3,222% | +$146M |
|
110
Agilent Technologies
A
$39.1B
| $159M | 0.18% |
2,370,200
+1,812,500
| +325% | +$122M |
|
|
TWX
111
DELISTED
Time Warner Inc
TWX
| $158M | 0.17% |
1,728,234
+35,600
| +2% | +$3.36M |
|
112
Devon Energy
DVN
$51.9B
| $154M | 0.17% |
3,713,200
+283,400
| +8% | +$10.7M |
|
113
Arch Capital
ACGL
$36.1B
| $154M | 0.17% |
5,077,500
+495,600
| +11% | +$15.8M |
|
114
Charles River Laboratories
CRL
$10.9B
| $153M | 0.17% |
1,398,700
+58,991
| +4% | +$6.42M |
|
115
CMS Energy
CMS
$23.1B
| $153M | 0.17% |
3,234,500
+1,329,800
| +70% | +$64.4M |
|
|
LNW
116
DELISTED
Light & Wonder
LNW
| $152M | 0.17% |
2,967,748
+424,762
| +17% | +$20.7M |
|
117
Republic Services
RSG
$66.7B
| $152M | 0.17% |
2,250,500
+217,500
| +11% | +$14M |
|
118
Chemours
CC
$2.59B
| $152M | 0.17% |
3,037,800
-1,602,600
| -35% | -$83.9M |
|
119
Elevance Health
ELV
$81.9B
| $151M | 0.17% |
671,600
-498,373
| -43% | -$106M |
|
120
GoDaddy
GDDY
$12.3B
| $150M | 0.17% |
2,992,900
+619,500
| +26% | +$29.4M |
|
|
XLNX
121
DELISTED
Xilinx Inc
XLNX
| $149M | 0.16% |
2,206,205
-124,200
| -5% | -$8.81M |
|
122
NextEra Energy
NEE
$187B
| $147M | 0.16% |
3,763,200
+64,800
| +2% | +$2.5M |
|
123
Franco-Nevada
FNV
$41.4B
| $146M | 0.16% |
1,823,500
+530,300
| +41% | +$42.6M |
|
124
Dolby
DLB
$4.72B
| $145M | 0.16% |
2,331,300
-80,035
| -3% | -$4.83M |
|
125
Novartis
NVS
$295B
| $144M | 0.16% |
1,915,168
+303,441
| +19% | +$22.9M |
|
Similar funds
Renaissance Technologies's Q4 2017 Portfolio in Review
As of Q4 2017, Renaissance Technologies held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Renaissance Technologies's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Renaissance Technologies added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Renaissance Technologies's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Renaissance Technologies fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Renaissance Technologies's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Renaissance Technologies opened 521 new positions and closed 386 in Q4 2017.
- Renaissance Technologies's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.